Ara Parseghian Medical Research Foundation

Join us in the Fight Against Niemann-Pick Type C Disease

Newsletter

Newsletters & Videos


"A Goal For Life"

The Ara Parseghian Medical Research Foundation Newsletter

-----
Donate Now

We invite you to read our newsletter, "A Goal For Life", which provides quick and easy access to information about what's new at Ara Parseghian Medical Research Foundation, research updates, fundraising stories and features about NP-C patients and families.

To the left, you can view videos that include messages from Cindy Parseghian and an interview with Ara Parseghian.

----------

Spring 2016

 

We are pleased to announce a new partnership with the University of Notre Dame which will help toensure APMRF’s momentum in pursuing a treatment for Niemann Pick Type–C disease. Notre Dame has launched the Ara Parseghian Medical Research Fund which will take on the administrative functions of the APMRF including fundraising, recruiting of researchers world-wide, grant administration, marketing, interaction with other NP-C families, and hosting of the annual science conference. The Parseghian family will continue to be intimately involved with the fundraising efforts and will act as advisors to the new Fund. A great deal of attention has been focused on this transition to ensure that the work we started over 22 years ago continues advancing the field of NP-C research.

Read More

--------------------

Winter 2015

 

Join us in welcoming 3 new Board Members to the Scientific Advisory Board:

  • Ed Holson, Ph.D., Entrepreneur in Residence and Chief Scientific Officer at KDAC Therapeutics.
  • Dan S. Ory, M.D., Director, Washington University Metabolomics Facility, Washington University School of Medicine.
  • Suzanne Pfeffer, Ph.D., Emma Pfeiffer Merner Professor of Medical Sciences and the Professor and Chairman of Biochemistry, Stanford University.

Read More


----------

Fall 2015

 

The 4th annual Parseghian Classic took place on June 26-29, 2015 and was an incredible event. With the perfect combination of ocean view golf, luxurious accommodations, delicious cuisine and excellent service – all of which was made possible with the heartfelt commitment and generosity of all who attended. Singer, songwriter Amy Grant once again brought her musical talent and her devotion to helping raise NP-C research funds and performed at the closing dinner. This year’s event, with the largest turnout yet, was filled to capacity with a waiting list. We ask…. “How can this get any better?” Well, we are going to try….and you can help by joining us next year! Mark your
calendars…. June 24-27, 2016.

Read More

--------------------

Winter 2014

 

Dedication...Boler-Parseghian Center for Rare & Neglected Diseases


Established in 2009, The Notre Dame Center for Rare & Neglected Diseases was recently named and dedicated to two families with longtime ties to the University of Notre Dame – The Boler Family and the Parseghian Family. The Boler family made a generous gift to ND to endow the Center and chose to name it in honor of their parents John and Mary Jo Boler and Michael, Marcia and Christa Parseghian,the children of Mike and Cindy Parseghian.

Read More

--------------------

Fall 2014

2014 NP-C Scientific Conference Highlights

 

The University of Notre Dame hosted the 20th NP-C Science Conference in June, bringing researchers from around the world to discuss the progress in NP-C research. This conference was made possible by an endowment the APMRF established to ensure the continuation of this very important meeting. It is the only large meeting specifically held for NP-C researchers so they can focus their attention on conquering the disease. The attendees also help formulate the plans for the direction of the research, highlighting special areas to be investigated.

Read More

 

--------------------

Spring 2014

Science Update

 

HDACi Drug Trial Expected To Start In 2014

Tremendous progress has been made to initiate a new, two-center drug trial later this year at the Mayo Clinic and NIH Clinical Center. To reach this goal a major collaborative effort is underway to determine if a histone deacetylase inhibitor (HDACi) can be used to safely treat patients with Niemann-Pick Disease, type C1 (NPC).

Read More

 

--------------------

Winter 2013

 

Hope for NP-C Patients


A clinical trial is expected to begin in the summer of 2014 using a Histone Deacetylase Inhibitors (HDACi). The goal of the Phase 1 clinical trial will be to establish the safety and tolerability of an oral HDACi as a treatment for NPC1 disease.

Read More

 

--------------------

Fall 2013

Parseghian Classic


Surrounded by the splendid beauty of Pebble Beach, this three day event held on June 21st-24th, was spectacular! Participants enjoyed rounds of golf on The Pebble Beach Golf Links and The Links at Spanish Bay, the camaraderie of old friends, new acquaintances, delicious cuisine, and a Sunday evening to remember. The evening’s special guests included Amanda Bane and her family. Amanda, age 21, was diagnosed with NP-C two years ago.

Read More

--------------------

 

 

   

---
© 2008 Ara Parseghian Medical Research Foundation
4729 E Sunrise Dr., #327, Tucson, Arizona 85718-4535, Phone: (520) 577-5106 Fax: (520) 577-5212, E-Mail: promano@parseghian.org